Zobrazeno 1 - 10
of 29
pro vyhledávání: '"K. Kabelitz"'
Autor:
Thomas Zwingers, H. J. Staiger, H. Radtke, E. Terhardt, W. Gassmann, P. Meusers, Eva Lengfelder, Hubert J. Stein, H. H. Gerhartz, T. Wagner, C. Schöber, F. Ludwig, Karl Lennert, M. G. Willems, Michael Hallek, W. Dornoff, W. Hettchen, Eckhard Thiel, Wolfgang Siegert, I. Meuthen, W. Enne, Markus Tiemann, M. Thomas, R. Kuse, J. Heise, Dieter Huhn, C. Schadeck, N. Brack, Wolfgang Wilmanns, K. Kabelitz, M. Engelhard, Günter Brittinger, E. Schumacher
Publikováno v:
Annals of Oncology. 2:177-180
In a prospective multicenter trial the efficiency of the response-adapted COP-BLAM/IMVP-16 protocol to induce complete remissions (CR) in high-grade malignant non-Hodgkin’s lymphomas as well as the prognostic relevance of adjuvant radiotherapy were
Autor:
Lutz Edler, U. Räth, P.M. Schlag, W. Queißer, J. Selbach, H. Flechtner, F.A. Trux, K. Kabelitz, H. Harjung, C. Manegold
Publikováno v:
Oncology Research and Treatment. 13:194-197
In a multicenter trial, 49 patients with histologically proven advanced gastric cancer were treated with a combination chemotherapy consisting of etoposide 120 mg/m2 d 4, 5, 6 adriamycin 20
Autor:
Marianne Engelhard, P. Meusers, G. Brittinger, N. Brack, W. Dornoff, W. Enne, W. Gassmann, H. Gerhartz, M. Hallek, J. Heise, W. Hettchen, D. Huhn, K. Kabelitz, R. Kuse, E. Lengfelder, F. Ludwig, I. Meuthen, H. Radtke, C. Schadeck, C. Schöber, E. Schumacher, W. Siegert, H.-J. Staiger, E. Terhardt, E. Thiel, M. Thomas, T. Wagner, M. G. Willems, W. Wilmanns, T. Zwingers, H. Stein, M. Tiemann, K. Lennert
Publikováno v:
Annals of Oncology ISBN: 9781489972941
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::673c74699a01d1c9572ef60ada0efb72
https://doi.org/10.1007/978-1-4899-7305-4_28
https://doi.org/10.1007/978-1-4899-7305-4_28
Autor:
U, Räth, H, Flechtner, J, Selbach, H, Harjung, C, Manegold, K, Kabelitz, F A, Trux, L, Edler, P, Schlag, W, Queisser
Publikováno v:
Onkologie. 13(3)
In a multicenter trial, 49 patients with histologically proven advanced gastric cancer were treated with a combination chemotherapy consisting of etoposide 120 mg/m2 d 4, 5, 6 adriamycin 20 mg/m2 d 1, 7 and cisplatinum 40 mg/m2 d 2, 8. Therapy was re
Autor:
K.-H. Zurborn, H. Seibt, R. Fuchs, D. Schlag, C. H. Hagen-Aukamp, Eva Lengfelder, Wolfgang Wilmanns, Wolfgang Siegert, R. Kuse, W. Enne, Marianne Engelhard, T. Zwingers, Karl Lennert, Günter Brittinger, Dieter Huhn, Bernd Dörken, H. J. Steiger, K. Kabelitz, E. Kaiser, W. Engert, Eckhard Thiel, M. Schäfers, H. H. Gerhartz
Publikováno v:
Blut. 56:139-142
Autor:
Eva Lengfelder, Eckhard Thiel, W. Kayser, H. J. Staiger, A. Stacker, Andreas Engert, Wolfgang Siegert, T. Zwingers, G. Brittinger, P. Meusers, M. Engelhard, R. Kuse, H. Seibt, A. Klüver, K. Kabelitz, B. Steinke, R. Heinz, K.-H. Zurborn, A. C. Feller, H. Radtke, Hubert J. Stein, Andreas Neubauer, Ch. Hagen-Aukamp, Dieter Huhn, Wolfgang Wilmanns, Karl Lennert, R. Fuchs, W.M. Glöckner, H. Gerhartz, Ch. V. Schilling, A. D. Ho, W. Enne, M. Schaefers
Publikováno v:
Oncology Research and Treatment. 11:30-34
Im Rahmen einer multizentrischen prospektiven randomisierten Studie zur Behandlung von Non-Hodgkin-Lymphomen (NHL) hoher Malignitat (Kiel-Klassifikation) der Stadien II-IV (Ann-Arbor-Klassifikation) w
Publikováno v:
Oncology Research and Treatment. 12:202-206
In a phase II trial 46 patients with advanced gastric carcinoma were treated with FEM combination chemotherapy (5-fluorouracil, 4-epidoxorubicin and mitomycin C) in which 4-epidoxorubicin was administered by escalated dose and split course (FEM II).
Autor:
H.H. Gerhartz, W. Wilmanns, G. Brittinger, M. Engelhard, R. Heinz, D. Huhn, P. Meusers, W. Siegert, A. Stacher, E. Thiel, H. Dietzfelbinger, B. Doerken, W. Dornoff, W. Enne, R. Fuchs, J. Heise, W. Hettchen, K. Kabelitz, R. Kuse, E. Lengfelder, H. Löffler, D. Metzner, L. Nowicki, H. Radtke, M. Schaefers, E. Schumacher, H. Seibt, H.J. Staiger, T. Wagner, M.G. Willems, K.H. Zurborn, T. Zwingers, A.C. Feller, C. v. Schilling, H. Stein, K. Lennert
Publikováno v:
Oncology Research and Treatment. 12:22-26
In a prospective multicenter therapy trial the remission-inducing potential of the COP-BLAM (5 courses) and the possibly not cross-resistant IMVP-16 (2 courses) regimen for advanced diffuse large cell lymphomas were investigated. Inadequately respond
Publikováno v:
Onkologie. 12(5)
In a phase II trial 46 patients with advanced gastric carcinoma were treated with FEM combination chemotherapy (5-fluorouracil, 4-epidoxorubicin and mitomycin C) in which 4-epidoxorubicin was administered by escalated dose and split course (FEM II).
Publikováno v:
Verhandlungen der Deutschen Gesellschaft fur Innere Medizin. 81